AMEDICA Corporation, a spinal and reconstructive medical device manufacturer, unveiled its new website, providing the community with a comprehensive resource on Silicon Nitride properties (Si3N4) for spine interbody fusion procedures and other orthopedic applications. Site enhancements and upgraded navigation capabilities now enable visitors to quickly find information on the company’s proprietary FDA-cleared Silicon Nitride technology for spinal fusion procedures as well as the latest company and industry news. In addition to improvements to the corporate site, surgeons, distributors and other visitors can now learn all about the benefits of the ceramic technology.
The company’s new site is an in-depth resource on the vast benefits of the ceramic biomaterial as well as short videos and an animation. Visitors will learn why the biomaterial’s exceptional properties offer numerous benefits to surgeons and patients alike, especially when compared with other materials used in spinal implant devices, such as polyether ether ketone (PEEK) or titanium (Ti).
AMEDICA also announced the expansion of biomaterial claims for its Silicon Nitride Interbody Fusion Devices. Data published in two peer-reviewed studies demonstrate that medical-grade Silicon Nitride provides superior osteointegration and anti-infective capabilities when compared to products comprised of PEEK or titanium.
Medical and scientific professionals talk about the many benefits of using Silicon Nitride (Si3N4) technology in spinal and orthopedic reconstructive surgery, including excellent osteoconductive properties, high wear resistance, and greatly improved compatibility with all imaging modalities. In the race to achieve interbody fusion, material matters. And no material fosters an environment for faster fusion like Silicon Nitride. Featuring the ability to achieve superior new bone growth and osteointegration, along with proven anti-infective properties and enhanced imaging attributes, Silicon Nitride outperforms PEEK and titanium.
AMEDICA’s Silicon Nitride inhibits biofilm formation and bacterial colonization. Silicon Nitride demonstrates significantly lower biofilm formation at 4, 24, 48 and 72 hours as compared to PEEK and titanium; live bacteria (S. epidermidis, S. aureus, P. aeruginosa, E. coli and Enterococcus) associated with Silicon Nitride implants are 8 to 30 times lower than PEEK and titanium. It also demonstrated bacteriostatic agents: in vivo studies, no infection is observed with bacteria-inoculated Silicon Nitride implants at 3 months, whereas both PEEK and titanium implants maintain a septic state. Silicon Nitride demonstrates this property even in the absence of antibiotics.
AMEDICA is not only the first, but the only company in the world with the FDA clearance to use Silicon Nitride properties to manufacture and distribute spinal implants. Using Silicon Nitride properties, AMEDICA hopes to transform the way spinal and orthopedic reconstructive surgeries are performed and bring new, highly advanced technology to surgeons and patients around the world.